RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      서울 지역을 대상으로 모집된 성인 아토피피부염 환자의 삶의 질과 경제적 비용 부담에 관한 조사 = Quality of Life and Economic Impact of Adult Atopic Dermatitis Patients in Seoul

      한글로보기

      https://www.riss.kr/link?id=A101009036

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Objective : Atopic dermatitis (AD) may profoundly affect patient's quality of life (QOL), and also cause economic impact. The aim of our study was to evaluate the quality of life and the economic impact of adult atopic dermatitis patient in Seoul. We also evaluate the relationship of QOL and economic impact with severity of AD. Methods : 30 adult atopic dermatitis patient were included and evaluated by using the SCORAD Index and EASI. Patients were asked to fill in the questionnaires about their quality of life and financial costs during the past year by AD. Data about sleep disturbance and pruritus were also obtained. Pearson's correlation were used for statistical analysis. Results : 1. Among 30 patients, women were 19(63.3%), men were 11(36.7%). The mean age of the patients were 27.3 years old, patients between the ages of 17 and 30 years were 23, over 30 were seven. 2. The mean score of Objective SCORAD was $32.89{\pm}7.30$, Subjective SCORAD was $8.13{\pm}3.53$ and EASI was $9.15{\pm}6.90$이었다. 3. The mean score of Skindex-29 was $28.26{\pm}7.58$, DLQI was $10.17{\pm}5.55$. 4. By analyzing the questionnaire, a monthly average cost of 583,200 won for each patient was determined. Direct cost was 236,800 won and indirect cost was 346,300 won. 5. By analyzing the correlation between the severity of AD and QOL, Objective SCORAD and EASI were positively correlated with QOL(Skindex-29, DLQI) but not significant, meanwhile subjective SCORAD were significantly and positively correlated with QOL(Skindex-29, DLQI). 6. By analyzing the correlation between the severity of AD and economic impact, Objective SCORAD were significantly and positively correlated with direct cost and indirect cost. Also, EASI were significantly and positively correlated with direct cost and oriental medical hospital visits. Conclusions : The above results show that the QOL of the patients with atopic dermatitis is significantly related to their disease severity. Atopic dermatitis patients pay 583,200 won a month, and the economic impact of the patients is significantly related to their disease severity.
      번역하기

      Objective : Atopic dermatitis (AD) may profoundly affect patient's quality of life (QOL), and also cause economic impact. The aim of our study was to evaluate the quality of life and the economic impact of adult atopic dermatitis patient in Seoul. We ...

      Objective : Atopic dermatitis (AD) may profoundly affect patient's quality of life (QOL), and also cause economic impact. The aim of our study was to evaluate the quality of life and the economic impact of adult atopic dermatitis patient in Seoul. We also evaluate the relationship of QOL and economic impact with severity of AD. Methods : 30 adult atopic dermatitis patient were included and evaluated by using the SCORAD Index and EASI. Patients were asked to fill in the questionnaires about their quality of life and financial costs during the past year by AD. Data about sleep disturbance and pruritus were also obtained. Pearson's correlation were used for statistical analysis. Results : 1. Among 30 patients, women were 19(63.3%), men were 11(36.7%). The mean age of the patients were 27.3 years old, patients between the ages of 17 and 30 years were 23, over 30 were seven. 2. The mean score of Objective SCORAD was $32.89{\pm}7.30$, Subjective SCORAD was $8.13{\pm}3.53$ and EASI was $9.15{\pm}6.90$이었다. 3. The mean score of Skindex-29 was $28.26{\pm}7.58$, DLQI was $10.17{\pm}5.55$. 4. By analyzing the questionnaire, a monthly average cost of 583,200 won for each patient was determined. Direct cost was 236,800 won and indirect cost was 346,300 won. 5. By analyzing the correlation between the severity of AD and QOL, Objective SCORAD and EASI were positively correlated with QOL(Skindex-29, DLQI) but not significant, meanwhile subjective SCORAD were significantly and positively correlated with QOL(Skindex-29, DLQI). 6. By analyzing the correlation between the severity of AD and economic impact, Objective SCORAD were significantly and positively correlated with direct cost and indirect cost. Also, EASI were significantly and positively correlated with direct cost and oriental medical hospital visits. Conclusions : The above results show that the QOL of the patients with atopic dermatitis is significantly related to their disease severity. Atopic dermatitis patients pay 583,200 won a month, and the economic impact of the patients is significantly related to their disease severity.

      더보기

      참고문헌 (Reference)

      1 김민희, "한국어판 skindex-29를 통해 본 피부과 환자의 삶의 질" 대한한의학회 26 (26): 43-54, 2005

      2 안봉균, "여드름 환자의 삶의 질 조사" 대한피부과학회 43 (43): 6-14, 2005

      3 진현우, "아토피피부염 환자의 대체의학 이용 실태에 관한 연구" 대한피부과학회 43 (43): 903-911, 2005

      4 이해성, "소아 아토피 피부염의 빈도와 원인의 변화 - 10년 전과 비교하여 -" 대한 소아알레르기 호흡기학회 12 (12): 263-281, 2002

      5 이희정, "성인 아토피피부염 환자에서 삶의 질 평가의 임상적 유용성" 대한피부과학회 45 (45): 159-164, 2007

      6 박장규, "백반증 환자의 삶의 질 평가" 대한피부과학회 46 (46): 874-880, 2008

      7 박현호, "건선 환자의 삶의 질" 대한피부과학회 42 (42): 151-156, 2004

      8 Mancini AJ, "The socioeconomic impact of atopic dermatitis in the United States: a systematic review" 25 (25): 1-6, 2008

      9 Fivenson D, "The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization" 8 : 333-342, 2002

      10 Anthony J. Mancini, "The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review" 25 (25): 1-6, 2008

      1 김민희, "한국어판 skindex-29를 통해 본 피부과 환자의 삶의 질" 대한한의학회 26 (26): 43-54, 2005

      2 안봉균, "여드름 환자의 삶의 질 조사" 대한피부과학회 43 (43): 6-14, 2005

      3 진현우, "아토피피부염 환자의 대체의학 이용 실태에 관한 연구" 대한피부과학회 43 (43): 903-911, 2005

      4 이해성, "소아 아토피 피부염의 빈도와 원인의 변화 - 10년 전과 비교하여 -" 대한 소아알레르기 호흡기학회 12 (12): 263-281, 2002

      5 이희정, "성인 아토피피부염 환자에서 삶의 질 평가의 임상적 유용성" 대한피부과학회 45 (45): 159-164, 2007

      6 박장규, "백반증 환자의 삶의 질 평가" 대한피부과학회 46 (46): 874-880, 2008

      7 박현호, "건선 환자의 삶의 질" 대한피부과학회 42 (42): 151-156, 2004

      8 Mancini AJ, "The socioeconomic impact of atopic dermatitis in the United States: a systematic review" 25 (25): 1-6, 2008

      9 Fivenson D, "The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization" 8 : 333-342, 2002

      10 Anthony J. Mancini, "The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review" 25 (25): 1-6, 2008

      11 Christie L. Carroll, "The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society" 22 (22): 192-199, 2005

      12 Finlay AY, "Quality of life in atopic dermatitis" 45 : 64-66, 2001

      13 Lewis-Jones S, "Quality of life and childhood atopic dermatitis : the misery of living with childhood eczema" 60 : 984-992, 2006

      14 Nicole Jenner, "Morbidity and cost of atopic eczema in Australia" 45 : 16-22, 2004

      15 Holm EA, "Life quality assessment among patients with atopic eczema" 154 : 719-725, 2006

      16 Chren MM, "Improved discriminative and evaluative capability of a refined version of Skindex-29, a quality-of-life instrument for patients with skin diseases" 133 : 1433-1440, 1997

      17 Anderson RT, "Effects of allergic dermatosis on health-related quality of life" 1 : 309-15, 2001

      18 Hanifin JM, "Diagnostic features of atopic dermatitis" 92 : 44-47, 1980

      19 Finlay AY, "Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use" 19 : 210-216, 1994

      20 Finlay AY, "Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use" 19 : 210-216, 1994

      21 Ellis CN, "Cost of atopic dermatitis and eczema in the United States" 46 : 361-370, 2002

      22 World Health Organization, "Constitution of the World Health Organization Basic Documents"

      23 Hon K, "CDLQI, Scorad and Ness: are they correlated?" 15 : 1551-1558, 2006

      24 Martin Barbeau M, "Burden of Atopic dermatitis in Canada" 45 (45): 31-36, 2006

      25 Lapidus CS, "Atopic dermatitis in children: who cares?ㅡ Who pays?" 28 : 699-703, 1993

      26 Giampaolo Ricci, "Atopic Dermatitis in Italian Children: Evaluation of Its Economic Impact" 20 (20): 311-315, 2006

      27 Beattie PE, "A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases" 155 : 145-151, 2006

      28 오재원, "1995년과 2000년의 학동기와 2003년 학동전기 소아에서의 아토피피부염의 역학적 변화에 관한 전국적인 연구" 대한 소아알레르기 호흡기학회 13 (13): 227-237, 2003

      29 Lewis V, "10 years experience of the Dermatology Life Quality Index (DLQI)" 9 : 169-180, 2004

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2020-03-09 학회명변경 영문명 : The Korean Oriental Opthalmology&Otolaryngology&Dermatology Society -> The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society KCI등재
      2020-03-05 학술지명변경 외국어명 : The Journal of Korean Oriental Ophthalmology&Otorhinolaryngology&Dermatology -> The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.87 0.87 0.88
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.91 0.87 0.749 0.1
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼